{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Papp A"],"funding":["Horizon 2020 Framework Programme","National Research, Development and Innovation Office","NHLBI NIH HHS","MedInProt Protein Science Research Synergy Program","National Institutes of Health","Magyar Tudományos Akadémia","Kidneeds"],"pagination":["845953"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8980529"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13"],"pubmed_abstract":["Components of the extracellular matrix (ECM), when exposed to body fluids may promote local complement activation and inflammation. Pathologic complement activation at the glomerular basement membrane and at the Bruch's membrane is implicated in renal and eye diseases, respectively. Binding of soluble complement inhibitors to the ECM, including factor H (FH), is important to prevent excessive complement activation. Since the FH-related (FHR) proteins FHR1 and FHR5 are also implicated in these diseases, our aim was to study whether these FHRs can also bind to ECM components and affect local FH activity and complement activation. Both FH and the FHRs showed variable binding to ECM components. We identified laminin, fibromodulin, osteoadherin and PRELP as ligands of FHR1 and FHR5, and found t"],"journal":["Frontiers in immunology"],"pubmed_title":["Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation."],"pmcid":["PMC8980529"],"funding_grant_id":["K125219, K109055","0106307","R01 HL112937","R01HL112937","899163"],"pubmed_authors":["Banlaki Z","Prohaszka Z","Cserhalmi M","Blom AM","Papp K","Csincsi AI","Ermert D","Szabo Z","Uzonyi B","Erdei A","Jozsi M","Papp A","Ferreira VP"],"additional_accession":[]},"is_claimable":false,"name":"Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation.","description":"Components of the extracellular matrix (ECM), when exposed to body fluids may promote local complement activation and inflammation. Pathologic complement activation at the glomerular basement membrane and at the Bruch's membrane is implicated in renal and eye diseases, respectively. Binding of soluble complement inhibitors to the ECM, including factor H (FH), is important to prevent excessive complement activation. Since the FH-related (FHR) proteins FHR1 and FHR5 are also implicated in these diseases, our aim was to study whether these FHRs can also bind to ECM components and affect local FH activity and complement activation. Both FH and the FHRs showed variable binding to ECM components. We identified laminin, fibromodulin, osteoadherin and PRELP as ligands of FHR1 and FHR5, and found t","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2026-03-18T13:40:38.822Z","creation":"2025-04-19T21:48:20.089Z"},"accession":"S-EPMC8980529","cross_references":{"pubmed":["35392081"],"doi":["10.3389/fimmu.2022.845953"]}}